Skip to main content
Premium Trial:

Request an Annual Quote

Almac Gets CLIA OK for Lab

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Almac Diagnostics today said that it has received CLIA certification for a new lab it has opened to support its biomarker discovery and development strategy.

Craigavon, Northern Ireland-based Almac said that the lab will support its own needs as well as those of its pharmaceutical partners.

"We have come to a point where the biomarkers we have discovered and assays that we have developed are being used to stratify patients, enrich clinical trials, and impact patient treatment decisions," Paul Harkin, president and managing director of Almac’s Diagnostics business, said in a statement. "As such, CLIA is a key necessity for the processing of these samples."

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.